|1.||Krishnan, Koyamangalath: 1 article (01/2014)|
|2.||Stone, William L: 1 article (01/2014)|
|3.||McGoldrick, Christopher A: 1 article (01/2014)|
|4.||Brannon, Marianne: 1 article (01/2014)|
|5.||Jiang, Yu-Lin: 1 article (01/2014)|
|6.||Serebryakova, Olga G: 1 article (10/2009)|
|7.||Makhaeva, Galina F: 1 article (10/2009)|
|8.||Sokolov, Vladimir B: 1 article (10/2009)|
|9.||Aksinenko, Alexey Y: 1 article (10/2009)|
|10.||Richardson, Rudy J: 1 article (10/2009)|
01/01/2014 - "OPH is a serine esterase/protease that is overexpressed in some human tumors and cancer cell lines. "
08/01/1990 - "Competitive substrates for serine esterase blocked killing by LCMV-specific CTL, but serine esterase-containing granules isolated from LCMV-induced CTL, in contrast to granules isolated from a rat natural killer cell tumor line, did not display detectable hemolytic activity. "
09/15/2000 - "Granzyme A, a proteolytic serine esterase, was also measured in tumor cell lysates. "
08/14/1987 - "Up and down regulation of serine esterase release from mouse cytotoxic T lymphocytes by tumor-promoting phorbol ester."
04/10/1997 - "NK cells from tumor-rejected animals show higher expression of Fas ligand and serine esterase granzyme B. "
01/01/1991 - "Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias."
03/01/1989 - "A newly developed anti-CD3 antibody (500A2) was used as an activation signal for EL4 lymphoma cells and allospecific cytotoxic T-cell clones (CTL), and the production of IL-2/IL-2 receptor in EL4 cells and serine esterase in CTL was determined. "
07/01/1991 - "Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis."
06/01/1985 - "Levels of serum amyloid A (SAA) and the activities of cathepsin D, beta-N-glucosaminidase, serine esterase, lactate dehydrogenase (LDH) and gamma glutamyl transpeptidase (GGT) were measured in the blood plasma during induction of amyloidosis. "
02/03/1992 - "In order to find out which hemostasis parameters would have the predictive value for the development of preeclampsia, modified antithrombin III (ATM, representative of the antithrombin III-serine esterase complex), tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), beta-thromboglobulin (BTG), antithrombin III (AT III), fibrinogen, fibrin(ogen) degradation product (FDP), FDP D-dimer and euglobulin lysis time (ELT) were measured in 20 normal non-pregnant women, 21 normal pregnant women, 6 high-risk pregnant women, 14 preeclampsia pregnant women, and 5 patients with disseminated intravascular coagulation (DIC). "
|2.||Fas Ligand Protein (Fas Ligand)
|4.||Interferon-alpha (Interferon Alfa)
|5.||Interleukin-2 Receptors (IL 2 Receptor)
|6.||Plasminogen Activators (Plasminogen Activator)
|7.||Tissue Plasminogen Activator (Alteplase)
|8.||Phosphoric Acid Esters (Organophosphates)
|9.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)